Institute Gustave Roussy
Paris
0 studies enrolling now · 2 studies all time
What they study most
Stage III or Stage IV Metastatic Melanoma That Has Not Been Previously Treated With a Selective BRAF Inhibitor, Thyroid Cancer, V600-mutated BRAF Metastatic Melanoma, V600-mutated BRAF Unresectable Melanoma